Elite genotypes of Bacopa monnieri, with high contents of BACOSIDE A (cas 11028-00-5) and Bacopaside I, from southern Western Ghats in India
-
Add time:08/20/2019 Source:sciencedirect.com
Bacopa monnieri (Brahmi) is a high value herbaceous medicinal species used for improving intellect and memory. In India, high demand of B. monnieri for the manufacture of herbal extracts and medicines prompts its collection in huge quantities from wild habitats, leading to the extinction of its genotypes. Wild accessions of B. monnieri show high variability in the levels of bioactive principles, and only few of them yield ‘elite’ contents. The objective of the present study is search for elite genotypes of B. monnieri in its wild germplasm across the south Indian State of Kerala. A precise HPTLC-densitometric method was adopted for simultaneous quantification of the bioactive saponins, BACOSIDE A (cas 11028-00-5) and Bacopaside I, in sixty accessions of B. monnieri originally collected from various locations in Kerala and grown under identical ecological conditions in a Field Gene Bank/Experimental Plot for four generations. These sixty B. monnieri accessions showed high variability in the contents of bioactive compounds, and three of them showed elite contents (>5.5%) of (Bacoside A + Bacopaside I), viz., 6.58, 6.55 and 5.56%. Total content of both bioactive constituents (Bacoside A + Bacopaside I) ranged from 2.06 to 6.58%. Bacoside A and Bacopaside I contents in these sixty accessions varied from 1.44 to 5.40% and 0.29 to 1.36%, respectively. The average content of (Bacoside A + Bacopaside I) in these sixty accessions of B. monnieri is 3.70 ± 0.72%. Elite genotypes of B. monnieri discovered in this study are potential entities for cultivation and genetic improvement, which could ultimately meet its commercial requirements.
We also recommend Trading Suppliers and Manufacturers of BACOSIDE A (cas 11028-00-5). Pls Click Website Link as below: cas 11028-00-5 suppliers
Prev:BACOSIDE A (cas 11028-00-5) and bromelain relieve dichlorvos induced changes in oxidative responses in mice serum
Next:Enhanced bacoside content in polyamine treated in-vitro raised Bacopa monnieri (L.) Wettst) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research articleZinc oxide nanoparticles (ZnO NP) mediated regulation of bacosides biosynthesis and transcriptional correlation of HMG-CoA reductase gene in suspension culture of Bacopa monnieri08/25/2019
- Production of BACOSIDE A (cas 11028-00-5), a memory enhancer from hairy root cultures of Bacopa monnieri (L.) Wettst08/24/2019
- Bacoside-A, an anti-amyloid natural substance, inhibits membrane disruption by the amyloidogenic determinant of prion protein through accelerating fibril formation08/23/2019
- Surface modified PLGA nanoparticles for brain targeting of Bacoside-A08/22/2019
- Enhanced bacoside content in polyamine treated in-vitro raised Bacopa monnieri (L.) Wettst08/21/2019
- BACOSIDE A (cas 11028-00-5) and bromelain relieve dichlorvos induced changes in oxidative responses in mice serum08/19/2019
- Protective propensity of BACOSIDE A (cas 11028-00-5) and bromelain on renal cholinesterases, γ-Aminobutyric acid and serotonin level of Mus musculus intoxicated with dichlorvos08/18/2019
- Attenuation of cytotoxicity induced by tBHP in H9C2 cells by Bacopa monniera and BACOSIDE A (cas 11028-00-5)08/17/2019
- Bacoside-A inhibits inflammatory cytokines and chemokine in experimental autoimmune encephalomyelitis08/16/2019